Section I
61 – 70 of 5055
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Temporal trends in relative survival of diffuse large B-cell lymphoma in Sweden and Denmark in the era of targeted and cellular therapies
- Contribution to journal › Letter
-
Mark
Availability and use of PET in patients with brain tumours – a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) survey
- Contribution to journal › Article
-
Mark
A Call for Common Sense in the Use of Molecular Imaging
(2025) In Journal of nuclear medicine : official publication, Society of Nuclear Medicine 66(9). p.1500-1501
- Contribution to journal › Letter
-
Mark
Prognostic relevance of CD163+ immune cells in patients with metastatic breast cancer
- Contribution to journal › Article
-
Mark
Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish setting
- Contribution to journal › Article
-
Mark
External validation of a multivariable prediction model for positive resection margins in breast-conserving surgery
- Contribution to journal › Article
-
Mark
Human proteome distribution atlas for tissue-specific plasma proteome dynamics
- Contribution to journal › Article
-
Mark
Cellular and molecular cartography of muscle-invasive bladder cancer: Who benefits from neoadjuvant chemotherapy?
(2025) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Global Transcriptional Complexity of Estrogen Receptor Low Positive Breast Cancers in a Prospective Swedish Population-based SCAN-B Cohort
(2025) In Clinical cancer research : an official journal of the American Association for Cancer Research 31(13). p.2695-2709
- Contribution to journal › Article
-
Mark
Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma
- Contribution to journal › Article
